ELEVAR THERAPEUTICS Trademark

Trademark Overview

On Monday, September 16, 2019, a trademark application was filed for ELEVAR THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELEVAR THERAPEUTICS trademark a serial number of 88985348. The federal status of this trademark filing is REGISTERED as of Tuesday, November 26, 2024. This trademark is owned by Elevar Therapeutics, Inc.. The ELEVAR THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments
elevar therapeutics

General Information

Serial Number88985348
Word MarkELEVAR THERAPEUTICS
Filing DateMonday, September 16, 2019
Status700 - REGISTERED
Status DateTuesday, November 26, 2024
Registration Number7579989
Registration DateTuesday, November 26, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 20, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized blue lowercase wording "ELEVAR" above the stylized gray lowercase wording "THERAPEUTICS". Above the letters "A" and "R" in "ELEVAR" is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.
Indication of Colors claimedThe color(s) blue, light blue, dark blue and gray is/are claimed as a feature of the mark.
Translation of Words in MarkThe English translation of the word "ELEVAR" in the mark is "to raise".
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesMedical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 24, 2019
Primary Code042
First Use Anywhere DateWednesday, October 16, 2019
First Use In Commerce DateWednesday, October 16, 2019

Trademark Owner History

Party NameElevar Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121
Party NameElevar Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121
Party NameElevar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121

Trademark Events

Event DateEvent Description
Tuesday, September 24, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 19, 2019NEW APPLICATION ENTERED
Wednesday, September 25, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, November 12, 2019ASSIGNED TO EXAMINER
Friday, November 15, 2019NON-FINAL ACTION WRITTEN
Friday, November 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 15, 2019NON-FINAL ACTION E-MAILED
Friday, May 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2020ASSIGNED TO LIE
Thursday, May 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 16, 2020FINAL REFUSAL WRITTEN
Thursday, May 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 16, 2020FINAL REFUSAL E-MAILED
Wednesday, December 16, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, December 17, 2020EXPARTE APPEAL RECEIVED AT TTAB
Thursday, December 17, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, December 17, 2020EX PARTE APPEAL-INSTITUTED
Friday, December 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 15, 2021PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
Friday, January 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 16, 2021EXPARTE APPEAL TERMINATED
Tuesday, January 19, 2021NON-FINAL ACTION WRITTEN
Tuesday, January 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 19, 2021NON-FINAL ACTION E-MAILED
Tuesday, February 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 20, 2021PUBLISHED FOR OPPOSITION
Wednesday, March 31, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 20, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 15, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 15, 2021SOU EXTENSION 1 FILED
Wednesday, December 15, 2021SOU EXTENSION 1 GRANTED
Friday, December 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 15, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 15, 2022SOU EXTENSION 2 FILED
Wednesday, June 15, 2022SOU EXTENSION 2 GRANTED
Friday, June 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022SOU EXTENSION 3 FILED
Thursday, December 8, 2022SOU EXTENSION 3 GRANTED
Saturday, December 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 7, 2023SOU EXTENSION 4 FILED
Wednesday, June 7, 2023SOU EXTENSION 4 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, December 13, 2023USE AMENDMENT FILED
Wednesday, December 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 13, 2023TEAS STATEMENT OF USE RECEIVED
Wednesday, December 13, 2023TEAS REQUEST TO DIVIDE RECEIVED
Friday, December 22, 2023DIVISIONAL PROCESSING COMPLETE
Friday, December 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Saturday, December 23, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, February 14, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, November 26, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 26, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics elevar cancer research field healthcare primarily professionals development treatments distributed